Principal Financial Group Inc Revolution Medicines, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$36.92 - $47.94 $416,273 - $540,523	-11,275 Reduced 46.55%	12,947 $586,000
Q2 2024 Jul 29, 2024	SELL	$30.14 - $40.68 $180,990 - $244,283	-6,005 Reduced 19.87%	24,222 $940,000
Q1 2024 Apr 29, 2024	BUY	$26.56 - $33.55 $876 - $1,107	33 Added 0.11%	30,227 $974,000
Q4 2023 Feb 07, 2024	BUY	$18.35 - $34.12 $103,016 - $191,549	5,614 Added 22.84%	30,194 $865,000
Q3 2023 Nov 02, 2023	SELL	$25.17 - $35.05 $18,877 - $26,287	-750 Reduced 2.96%	24,580 $680,000
Q2 2023 Aug 07, 2023	BUY	$20.28 - $27.0 $56,236 - $74,871	2,773 Added 12.29%	25,330 $677,000
Q1 2023 May 09, 2023	BUY	$20.76 - $30.09 $78,597 - $113,920	3,786 Added 20.17%	22,557 $488,000
Q4 2022 Feb 09, 2023	BUY	$17.68 - $25.53 $37,110 - $53,587	2,099 Added 12.59%	18,771 $447,000
Q3 2022 Nov 09, 2022	BUY	$17.46 - $26.0 $71,271 - $106,132	4,082 Added 32.42%	16,672 $329,000
Q2 2022 Aug 10, 2022	BUY	$14.54 - $27.17 $61,867 - $115,608	4,255 Added 51.05%	12,590 $245,000
Q1 2022 May 09, 2022	SELL	$17.31 - $26.4 $8,135 - $12,408	-470 Reduced 5.34%	8,335 $213,000
Q4 2021 Feb 09, 2022	SELL	$24.35 - $33.7 $134,752 - $186,495	-5,534 Reduced 38.59%	8,805 $222,000
Q3 2021 Nov 09, 2021	SELL	$23.95 - $33.41 $228,722 - $319,065	-9,550 Reduced 39.98%	14,339 $394,000
Q2 2021 Aug 10, 2021	BUY	$29.0 - $47.44 $3,712 - $6,072	128 Added 0.54%	23,889 $758,000
Q1 2021 May 10, 2021	BUY	$37.21 - $54.43 $13,916 - $20,356	374 Added 1.6%	23,761 $1.09 Million
Q4 2020 Feb 08, 2021	BUY	$30.19 - $45.49 $530,287 - $799,031	17,565 Added 301.7%	23,387 $926,000
Q3 2020 Nov 06, 2020	BUY	$22.61 - $34.8 $131,635 - $202,605	5,822 New	5,822 $202,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

Vanguard Group Inc Valley Forge, PA

14.9M
Shares

$646 Million
0.01% of portfolio
Black Rock Inc. New York, NY

13.4M
Shares

$580 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

11.4M
Shares

$494 Million
0.09% of portfolio
Farallon Capital Management LLC San Francisco, CA

11.3M
Shares

$490 Million
2.58% of portfolio
Baker Bros. Advisors LP New York, NY

7.57M
Shares

$328 Million
3.67% of portfolio

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account